 Arcadia Biosciences Inc NASDAQ: RKDA reported fourth-quarter revenue declined 70 year-over-year to 2.17 million, missing the consensus of 3.33 million. Net loss was 9.3 million of 0.42 per share, compared to the 8.9 million of income recognized in 4Q20, missing the consensus. 